Preparation of Barije (Ferula gummosa) Essential Oil-Loaded Liposomes and Evaluation of Physical and Antibacterial Effect on Escherichia coli O157:H7

被引:21
|
作者
Najafi, Masoud Najaf [1 ]
Arianmehr, Anita [2 ]
Sani, Ali Mohammadi [2 ]
机构
[1] Agr Res Educ & Extens Org, Khorasan Razavi Agr & Nat Resources Res & Educ Ct, Mashhad 9176983641, Razavi Khorasan, Iran
[2] Islamic Azad Univ, Dept Food Sci & Technol, Quchan Branch, Quchan, Iran
关键词
Antimicrobial agent; Barije essential oil; Cholesterol; Escherichia coli; Nanoliposome; ETHANOL INJECTION METHOD; FORMULATION; ENTRAPMENT; STABILITY; VESICLES;
D O I
10.4315/0362-028X.JFP-19-285
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The aim of this study was to load liposomes with Barije (Ferula gummosa) essential oil (EO) and to evaluate their physical and antibacterial properties. Liposomes were produced with specific ratios of lecithin/cholesterol by thin-film hydration and sonication. The chemical composition of the EO was analyzed by gas chromatography and mass spectroscopy. The physical properties of the liposomes (particle size, polydispersity index, zeta potential, and encapsulation efficiency) were evaluated. The antimicrobial effects of these liposomes against Escherichia coli O157:H7 were determined based on the MIC and disk diffusion results. The effect of subinhibitory concentrations (sub-MICs) of EO against the growth of the bacterium over 24 h was evaluated before and after encapsulation. The major components of EO were beta-pinene (60.84%) and a-pinene (9.14%). The mean liposome radius of EO-loaded liposomes was 74.27 to 99.93 nm, which was significantly different from that of the empty liposomes (138.76 nm) (P, 0.05). Addition of cholesterol to the lecithin bilayer increased the particle size and reduced the encapsulation efficiency (P, 0.05). The electrostatic stability of the empty liposomes was improved by adding cholesterol, but when the EO was replaced in the liposomes, there was no significant change in electrostatic stability of liposomes with cholesterol (P, 0.05). MICs were 14.5 mu g/mL for the EO-loaded nanoliposomes containing 30 mg of lecithin and 30 mg of cholesterol and 10 mu g/mL for nonencapsulated EO. This trend was confirmed by measuring the inhibition zone diameter. SubMICs of liposomal EO (containing 60 mg of lecithin) decreased bacterial levels to a greater degree than did free EO, especially at 50 and 75% of the MIC.
引用
收藏
页码:511 / 517
页数:7
相关论文
共 50 条
  • [31] Escherichia coli O157:H7, an emerging pathogen
    Mariani-Kurkdjian, P
    Bingen, E
    PRESSE MEDICALE, 1999, 28 (37): : 2067 - 2074
  • [32] Thermal inactivation of Escherichia coli O157:H7
    Stringer, SC
    George, SM
    Peck, MW
    JOURNAL OF APPLIED MICROBIOLOGY, 2000, 88 : 79S - 89S
  • [33] Suspected Escherichia coli O157:H7 in beef
    不详
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2007, 5 (03) : 338 - 339
  • [34] Enterohemorrhagic Escherichia coli O157:H7 infection
    Shinoda, S
    Yamamoto, S
    Tomochika, K
    Miyoshi, S
    JAPANESE JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH, 1997, 43 (01): : 1 - 14
  • [35] An Escherichia coli O157:H7 outbreak?: Reply
    Friedman, MS
    CLINICAL INFECTIOUS DISEASES, 2000, 30 (06) : 984 - 984
  • [36] Microarray analysis of Escherichia coli O157:H7
    Jin, Hui-Ying
    Tao, Kai-Hua
    Li, Yue-Xi
    Li, Fa-Qing
    Li, Su-Qin
    WORLD JOURNAL OF GASTROENTEROLOGY, 2005, 11 (37) : 5811 - 5815
  • [37] Pseudomembranous colitis with Escherichia coli O157:H7
    Uc, A
    Mitros, FA
    Kao, SCS
    Sanders, KD
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 1997, 24 (05): : 590 - 593
  • [38] Absence of Escherichia coli O157:H7 in waters
    Belloso, CO
    INTERDISCIPLINARY PERSPECTIVES ON DRINKING WATER RISK ASSESSMENT AND MANAGEMENT, 2000, (260): : 33 - 35
  • [39] Canada and the USA:: Escherichia coli O157:H7
    不详
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2007, 5 (06) : 920 - 920
  • [40] Escherichia coli O157:H7 infection in Colombia
    Mattar, S
    Vasquez, E
    EMERGING INFECTIOUS DISEASES, 1998, 4 (01) : 126 - 127